Hong Kong stocks surged again | WuXi Biologics (02269.HK) rose by more than 3% and announced the construction of a modular biopharmaceutical production plant in its Singapore CRDMO center.
According to the Wisdom Financial APP, WuXi Biologics (02269.HK) has risen by over 3% again, up 2.83% as of the time of writing, to HK$34.55, with a trading volume of HK$1.387 billion.
Latest
